3.74
-0.18 (-4.59%)
| Previous Close | 3.92 |
| Open | 3.74 |
| Volume | 183 |
| Avg. Volume (3M) | 1,156 |
| Market Cap | 126,359,640 |
| Price / Earnings (TTM) | 2.70 |
| 52 Weeks Range | |
| Earnings Date | 15 May 2025 |
| TTM Dividend Yield | 2.67% |
| Profit Margin | 0.79% |
| Operating Margin (TTM) | 3.18% |
| Diluted EPS (TTM) | 1.38 |
| Quarterly Revenue Growth (YOY) | 2.70% |
| Quarterly Earnings Growth (YOY) | -53.50% |
| Total Debt/Equity (MRQ) | 53.69% |
| Current Ratio (MRQ) | 1.53 |
| Operating Cash Flow (TTM) | 70.24 M |
| Levered Free Cash Flow (TTM) | 8.45 M |
| Return on Assets (TTM) | 2.05% |
| Return on Equity (TTM) | 2.78% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Specialty Chemicals (GB) | Mixed | Mixed |
| Specialty Chemicals (Global) | Bearish | Bearish | |
| Stock | H&R GMBH & CO KGAA H&R ORD SHS | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -3.0 |
| Average | -0.38 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| H&R GMBH & CO KGAA H&R ORD SHS | 126 M | 2.67% | 2.70 | - |
| ALBEMARLE CORP ALBEMARLE ORD SH | 8 B | 2.96% | 32.49 | - |
| 0H7I | 3 B | 0.27% | 10.41 | - |
| CHEMOURS CO CHEMOURS ORD SHS | 2 B | 8.35% | 2.93 | - |
| ITACONIX PLC ORD 50P | 16 M | - | - | 1.87 |
| GURIT HOLDING AG GURIT HOLDING | 7 M | - | 0.657 | - |
|
H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. The company organizes its operating activities into two business divisions: Chemical-Pharmaceutical Raw Materials and Plastics. It also has three business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastics segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives the majority of its revenue from the ChemPharm Refining segment within Germany. |
|
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Investment Style | Small Value |
| % Held by Insiders | 67.51% |
| % Held by Institutions | 1.40% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |